Fourteen new thiazolyl hydrazone derivatives were synthesized and evaluated for their anticandidal activity using a broth microdilution assay. Among the synthesized compounds, 2-[2-((5-(4-chloro-2-nitrophenyl)furan-2-yl)methylene)hydrazinyl]- 4-(4-fluorophenyl)thiazole and 2-[2-((5-(4-chloro-2-nitrophenyl)furan-2-yl)methylene) hydrazinyl]-4-(4-methoxyphenyl)thiazole were found to be the most effective antifungal compounds against Candida utilis, with a MIC value of 250 μg/mL, when compared with fluconazole (MIC = 2 μg/mL). Additionally, the synthesized compounds were evaluated for their in vitro cytotoxic effects on the MCF-7 and NIH/3T3 cell lines. As a result, 2-[2- ((5-(4-chloro-2-nitrophenyl)furan-2-yl)methylene)hydrazinyl]-4-(4-chlorophenyl)thiazole was identified as the most promising anticancer compound against MCF-7 cancer cells due to its inhibitory effects (IC50 = 125 μg/mL) and relatively low toxicity towards the NIH/3T3 cell line (IC50 > 500 μg/mL).
CITATION STYLE
Altintop, M. D., Özdemir, A., Turan-Zitouni, G., Ilgin, S., Atli, Ö., Demirci, F., & Kaplancikli, Z. A. (2014). Synthesis and in vitro evaluation of new nitro-substituted thiazolyl hydrazone derivatives as anticandidal and anticancer agents. Molecules, 19(9), 14809–14820. https://doi.org/10.3390/molecules190914809
Mendeley helps you to discover research relevant for your work.